News
Tripura Chief Minister Manik Saha on Wednesday reiterated the state government's commitment to strengthening healthcare delivery in the state and urged citizens to make full use of the available ...
6d
The Print on MSNAtal Bihari Vajpayee called Farooq Abdullah a langoor for his theatrics at the UN over Kashmir
Believer’s Dilemma’, is the the second part of Abhishek Choudhary’s biography of Atal Bihari Vajpayee. In it, he covers the ...
Health Care His Kidney Failed. He’ll Never Know if a Transplant Drug From a Banned Factory Was to Blame. When Joe DeMayo’s donated kidney started to fail earlier than expected, he didn’t ...
A 61-year-old man presented with hypoxemic respiratory failure and shock 10 weeks after kidney transplantation. A purpuric rash was present on the abdomen. A diagnosis was made.
Dr. Michael Serzan provides expert takeaways on treatment updates for patients with early-stage kidney cancer following the 2025 ASCO Meeting.
Otsuka Pharmaceutical has shared more detailed data behind its kidney disease drug’s phase 3 win, showing the monoclonal antibody halved patients’ urine protein-to-creatinine ratio (UPCR) levels.
NICE reversed its earlier decision on sparsentan for treating primary immunoglobulin A nephropathy after additional evidence and a price reduction from the manufacturer.
IgA Nephropathy (IgAN) is a common kidney disease and a main cause of kidney failure and chronic kidney disease. Read more about its symptoms, causes, risk factors, complications and treatments.
A Twin Cities woman is suing over an alleged medical mistake that she says cost her a healthy left kidney. In a lawsuit filed Friday, Wendy Rappaport of Plymouth accuses the surgeon and the Allina ...
Mawuton continues to receive treatment at Zenith Medical and Kidney Centre, Atom Kpera Close, Gudu District, Abuja , a renowned hospital for nephrology and kidney-related interventions.
Real-world data supports tolvaptan use to slow kidney function decline in patients with autosomal dominant polycystic kidney disease (ADPKD).
DaVita shares lost ground Monday after the dialysis services firm revealed it had suffered a ransomware attack.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results